Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Burkitt Lymphoma 5 Prostatic Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 2 Hodgkin Disease 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Plasmablastic Lymphoma 1 Neuroblastoma 1 Lymphoma, T-Cell 1 Lymphoma, Primary Effusion 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Leukemia, Biphenotypic, Acute 1 Immunoblastic Lymphadenopathy 1 HIV Infections 1 Enteropathy-Associated T-Cell Lymphoma 1 Composite Lymphoma 1 Blast Crisis 1

Interventions

Rituximab 134 Cyclophosphamide 126 Peripheral Blood Stem Cell Transplantation 74 fludarabine phosphate 71 Filgrastim 62 Etoposide 56 Bortezomib 44 Vincristine 43 Mycophenolic Acid 43 Whole-Body Irradiation 42 Cytarabine 42 Cyclosporine 41 Melphalan 38 Doxorubicin 37 Radiotherapy 36 Busulfan 35 ibrutinib 34 Tacrolimus 34 Methotrexate 33 Prednisone 32 Lenalidomide 30 Bendamustine Hydrochloride 30 Antilymphocyte Serum 27 Dexamethasone 26 Carmustine 26 Granulocyte Colony-Stimulating Factor 23 ibritumomab tiuxetan 20 sargramostim 17 fludarabine 17 Methylprednisolone 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Lymphoma, Mantle-Cell × prednylidene × Clear all

NCT02858804 2026-02-11

BDH-MCL01

Institute of Hematology & Blood Diseases Hospital, China

Phase 4 Completed

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡